Molecular risk stratification in advanced heart failure patients

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1443-1452

  Lamirault, Guillaume ^a,b,c   Meur, Nolwenn Le ^a,b,c   Roussel, Jean Christian ^c   Cunff, Marie France Le ^a,b,c   Baron, Daniel ^a,b,c   Bihouée, Audrey ^a,b,c   Guisle, Isabelle ^a,b,c   Raharijaona, Mahatsangy ^a,b,c   Ramstein, Gérard ^d   Teusan, Raluca ^a,b,c   Chevalier, Catherine ^a,b,c   Gueffet, Jean Pierre ^a,b,c   Trochu, Jean Noël ^a,b,c   Léger, Jean J ^a,b,c   Houlgatte, Rémi ^a,b,c   Steenman, Marja ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE RECHERCHE EN COMMUNICATIONS ET CYBERNÉTIQUE DE NANTES   (France)

Author keywords

Genes; Heart failure; Microarrays; Remodelling; Ventricles

Indexed keywords

ARTICLE; CLUSTER ANALYSIS; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RISK ASSESSMENT;

BIAS (EPIDEMIOLOGY); CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 77955141459     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00913.x     Document Type: Article

References (30)

1. Lee DS, Austin PC, Rouleau JL. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003, 290:2581-7.
2. Levy WC, Mozaffarian D, Linker DT. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006, 113:1424-33.
3. Aaronson KD, Schwartz JS, Chen TM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997, 95:2660-7.
4. Smits JM, Deng MC, Hummel M. A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates. Transplantation. 2003, 76:1185-9.
5. Francis GS. Pathophysiology of chronic heart failure. Am J Med. 2001, 110:37S-46S.
6. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999, 79:215-62.
7. Blaxall BC, Tschannen-Moran BM, Milano CA. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol. 2003, 41:1096-106.
8. Kaynak B, von Heydebreck A, Mebus S. Genome-wide array analysis of normal and malformed human hearts. Circulation. 2003, 107:2467-74.
9. Liew CC, Dzau VJ. Molecular genetics and genomics of heart failure. Nat Rev Genet. 2004, 5:811-25.
10. Kittleson MM, Ye SQ, Irizarry RA. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation. 2004, 110:3444-51.
11. Steenman M, Lamirault G, Le Meur N. Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur J Heart Fail. 2005, 7:157-65.
12. Renlund DG, Taylor DO, Kfoury AG. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant. 1999, 18:1065-70.
13. Eisen MB, Spellman PT, Brown PO. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95:14863-8.
14. Zeeberg BR, Feng W, Wang G. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003, 4:R28.
15. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001, 98:5116-21.
16. Tibshirani R, Hastie T, Narasimhan B. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA. 2002, 99:6567-72.
17. Heidecker B, Kasper EK, Wittstein IS. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation. 2008, 118:238-46.
18. Kaab S, Barth AS, Margerie D. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J Mol Med. 2004, 82:308-16.
19. Wittchen F, Suckau L, Witt H. Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med. 2007, 85:257-71.
20. Boheler KR, Volkova M, Morrell C. Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci USA. 2003, 100:2754-9.
21. Rogers JG, Butler J, Lansman SL. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007, 50:741-7.
22. Lietz K, Long JW, Kfoury AG. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007, 116:497-505.
23. Deng MC, Smits JM, Packer M. Selecting patients for heart transplantation: which patients are too well for transplant? Curr Opin Cardiol. 2002, 17:137-44.
24. Metra M, Ponikowski P, Dickstein K. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007, 9:684-94.
25. Stevenson LW, Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol. 2007, 50:748-51.
26. Hystad ME, Geiran OR, Attramadal H. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand. 2001, 171:395-403.
27. Potapov EV, Hennig F, Wagner FD. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg. 2005, 27:899-905.
28. Miller WL, Burnett JC, Hartman KA. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005, 96:837-41.
29. Bruins S, Fokkema MR, Romer JW. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem. 2004, 50:2052-8.
30. Lowes BD, Gilbert EM, Abraham WT. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002, 346:1357-65.